ID29295A - Senyawa pirimidinona, komposisi farmasi yang mengandung senyawa tersebut dan proses penyediaannya senyawa tersebut - Google Patents

Senyawa pirimidinona, komposisi farmasi yang mengandung senyawa tersebut dan proses penyediaannya senyawa tersebut

Info

Publication number
ID29295A
ID29295A IDW991643A ID991643A ID29295A ID 29295 A ID29295 A ID 29295A ID W991643 A IDW991643 A ID W991643A ID 991643 A ID991643 A ID 991643A ID 29295 A ID29295 A ID 29295A
Authority
ID
Indonesia
Prior art keywords
compound
supplying
pharmaceutical composition
pyrimidinone compounds
pyrimidinone
Prior art date
Application number
IDW991643A
Other languages
English (en)
Indonesian (id)
Inventor
Lee Jae Hyoung
Jang Kyung-Jin
Yoo Byoung-Wug
Kim Ji-Han
Kang Jae-Seog
Kim Sang-Lin
Original Assignee
Boryung Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=19536698&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID29295(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boryung Pharm filed Critical Boryung Pharm
Publication of ID29295A publication Critical patent/ID29295A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IDW991643A 1998-04-25 1999-04-26 Senyawa pirimidinona, komposisi farmasi yang mengandung senyawa tersebut dan proses penyediaannya senyawa tersebut ID29295A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019980014821A KR19990081093A (ko) 1998-04-25 1998-04-25 피리미디논 화합물, 이를 함유하는 약제학적 조성물 및 이의제조방법

Publications (1)

Publication Number Publication Date
ID29295A true ID29295A (id) 2001-08-16

Family

ID=19536698

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW991643A ID29295A (id) 1998-04-25 1999-04-26 Senyawa pirimidinona, komposisi farmasi yang mengandung senyawa tersebut dan proses penyediaannya senyawa tersebut

Country Status (13)

Country Link
US (1) US6294542B1 (ru)
EP (1) EP0991627B1 (ru)
JP (1) JP3351539B2 (ru)
KR (2) KR19990081093A (ru)
CN (1) CN1195741C (ru)
AU (1) AU753424B2 (ru)
BR (1) BR9906373B1 (ru)
CA (1) CA2295446C (ru)
DE (1) DE69909209T2 (ru)
ES (1) ES2209421T3 (ru)
ID (1) ID29295A (ru)
RU (1) RU2233278C9 (ru)
WO (1) WO1999055681A1 (ru)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100617953B1 (ko) * 2000-03-23 2006-08-30 보령제약 주식회사 피리미디논 화합물 및 이의 염의 제조방법
CN1273465C (zh) * 2001-09-21 2006-09-06 保宁制药株式会社 嘧啶酮化合物及其药学上可接受的盐的制备方法
KR100521980B1 (ko) * 2002-10-10 2005-10-17 보령제약 주식회사 피리미디논 화합물 및 이의 염의 삼수화물의 제조 방법
CN102666496B (zh) * 2010-01-21 2015-05-20 保宁制药株式会社 2-(2-正丁基-4-羟基-6-甲基-嘧啶-5-基)-n,n-二甲基乙酰胺的制备方法
MY160432A (en) * 2011-04-12 2017-03-15 Boryung Pharm Antihypertensive pharmaceutical composition
KR101490329B1 (ko) * 2012-10-12 2015-02-04 보령제약 주식회사 피마살탄 포타슘염의 일수화물 결정, 그 제조방법, 및 그를 포함하는 약제학적 조성물
KR20170006938A (ko) 2015-07-10 2017-01-18 보령제약 주식회사 만성 신부전의 예방 또는 치료용 조성물
CN105061405A (zh) * 2015-08-04 2015-11-18 合肥创新医药技术有限公司 非马沙坦钾盐三水合物的制备方法
KR102233673B1 (ko) 2016-01-27 2021-03-30 보령제약 주식회사 당뇨병성 신장질환의 예방 또는 치료용 약학적 조성물
CN105837514B (zh) * 2016-01-29 2018-09-18 北京睿创康泰医药研究院有限公司 非马沙坦药物杂质的制备方法
WO2018002673A1 (en) 2016-07-01 2018-01-04 N4 Pharma Uk Limited Novel formulations of angiotensin ii receptor antagonists
KR101984121B1 (ko) * 2017-08-21 2019-05-30 보령제약 주식회사 피리미디논 유도체 화합물 및 이의 용도
KR102078691B1 (ko) 2017-11-30 2020-02-19 보령제약 주식회사 피마살탄을 포함하는 고체 분산체
KR102201396B1 (ko) 2017-11-30 2021-01-11 보령제약 주식회사 피마살탄을 포함하는 약학적 조성물
KR20200073676A (ko) 2018-12-14 2020-06-24 엠에프씨 주식회사 발사탄 및 사쿠비트릴을 포함하는 고체 분산체 및 이를 포함하는 약학 조성물 및 이의 제조 방법
CN109485640B (zh) * 2018-12-24 2021-03-26 合肥创新医药技术有限公司 一种非马沙坦杂质的制备方法
CN112876424B (zh) * 2019-11-29 2023-06-30 上海拓界生物医药科技有限公司 血管紧张素ii受体及内皮素受体双重拮抗剂
KR102221856B1 (ko) * 2020-10-12 2021-03-02 유니셀랩 주식회사 신규한 피마살탄 결정형의 다형체
KR20220154987A (ko) 2021-05-14 2022-11-22 주식회사 보령 허혈성 뇌졸중 또는 일과성 허혈 발작을 갖는 대상체에서의 혈압 조절을 위한 약학적 조성물
KR20220162456A (ko) 2021-06-01 2022-12-08 주식회사 보령 고혈압을 동반한 당뇨병성 신장질환의 예방 또는 치료용 약학적 조성물
KR20240146734A (ko) 2023-03-30 2024-10-08 (주) 에프엔지리서치 피마살탄의 신규 염 및 이의 제조방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5100897A (en) * 1989-08-28 1992-03-31 Merck & Co., Inc. Substituted pyrimidinones as angiotensin ii antagonists
US5014228A (en) 1989-09-21 1991-05-07 Schlumberger Technologies, Inc. Method and apparatus for calibrating linear delay lines
JPH04120072A (ja) * 1990-09-11 1992-04-21 Meiji Seika Kaisha Ltd アンジオテンシン２拮抗性ピリミジン誘導体
EP0481614A1 (en) 1990-10-01 1992-04-22 Merck & Co. Inc. Substituted pyridopyrimidinones and related heterocycles as angiotensin II antagonists
EP0550313A1 (fr) 1991-12-30 1993-07-07 Synthelabo Nouveaux dérivés de 2-(tétrazol-5-yl)-(1,1'-biphényle), leur préparation et leur utilisation comme intermédiaires de synthèse
FR2688505B1 (fr) 1992-03-16 1994-05-06 Synthelabo Nouveau procede de preparation de 4-pyrimidinones.
FR2700543B1 (fr) 1993-01-15 1995-03-17 Synthelabo Sels de dérivés de 4-pyrimidinone, leur préparation et leur application en thérapeutique.
JPH07157485A (ja) * 1993-12-02 1995-06-20 Nkk Corp 縮合ピリミジノン誘導体及びそれらを含有するアンジオテンシンｉｉ拮抗剤
KR100300566B1 (ko) 1994-09-17 2001-11-22 조생현 피리미디논유도체와그의제조방법및용도

Also Published As

Publication number Publication date
JP3351539B2 (ja) 2002-11-25
AU753424B2 (en) 2002-10-17
CN1266428A (zh) 2000-09-13
RU2233278C2 (ru) 2004-07-27
AU3443899A (en) 1999-11-16
CN1195741C (zh) 2005-04-06
KR100354654B1 (ko) 2002-09-30
CA2295446C (en) 2009-01-06
DE69909209T2 (de) 2004-06-03
CA2295446A1 (en) 1999-11-04
EP0991627A1 (en) 2000-04-12
EP0991627B1 (en) 2003-07-02
RU2233278C9 (ru) 2009-11-27
WO1999055681A1 (en) 1999-11-04
KR19990081093A (ko) 1999-11-15
KR20010013626A (ko) 2001-02-26
DE69909209D1 (de) 2003-08-07
BR9906373A (pt) 2000-07-11
JP2001508469A (ja) 2001-06-26
BR9906373B1 (pt) 2010-11-16
US6294542B1 (en) 2001-09-25
ES2209421T3 (es) 2004-06-16

Similar Documents

Publication Publication Date Title
ID24929A (id) Turunan 2-aril-8-oksodihidropurin, proses pembuatannya, komposisi farmasinya yang mengandungnya, dan senyawa antaranya
ID29295A (id) Senyawa pirimidinona, komposisi farmasi yang mengandung senyawa tersebut dan proses penyediaannya senyawa tersebut
ID26399A (id) Turunan 1-(1-tersubstitusi-4-piperidinil) metil -4-piperidin, proses pembuatannya, komposisi farmasi yang mengandung senyawa tersebut, dan intermedietnya
ID30299A (id) Turunan oksazolidinon, proses pembuatannya dan komposisi farmasi yang mengandungnya
PL335154A1 (en) Disubstituted bicyclic heterocyclic compounds, their production and application as pharmaceutic compositions
ID21045A (id) Asam amino termodifikasi, obat-obatan yang mengandung senyawa ini dan proses pembuatannya
HUP0100765A3 (en) Composition for the treatment of halitosis
IL135574A0 (en) Substituted 4-amino-thiazol-2-yl compounds as cdk inhibitors
HUP0203766A3 (en) 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof and pharmaceutical compositions containing them
HK1045693B (zh) 新組合物和使該組合物穩定的方法
ID16128A (id) Turunan arilglisinamida baru, proses pembuatannya dan komposisi-komposisi farmasi yang mengandung senyawa ini
ID20137A (id) Turunan propanolamina, proses pembuatannya, sediaan farmasi yang mengandung senyawa ini, dan penggunannya
HUP0003982A3 (en) The use of inhibitors of the renin-angiotensin system for producing pharmaceutical compositions using for the treatment of hypoxia or impaired metabolic function
ID23436A (id) Senyawa-senyawa akrilonitril, proses untuk produksinya dan pestisida-pestisida yang mengandungnya
ID17810A (id) Turunan-turunan 2,4-tiazolidindion tersubstitusi baru, proses untuk pembuatannya dan komposisi farmasi yang mengandungnya
PL338004A1 (en) Derivatives of azetidinylpropylpiperidine, intermediate compounds and application of such derivatives as antagonists of tachykinins
HUP0002117A3 (en) Clear, injectable formulation of an anesthetic compound
ID22572A (id) Proses yang disempurnakan untuk pembuatan 3,5,5-trimetilsikloheksa-3-en-1-on (betha-isoforon) dengan isomerisasi 3,5,5-trimetilsikloheksa-2-en-1-on (alpha-isoforon) (ii)
TR199903132A3 (tr) Metalosan bilesiklerinin aktive edici kompozisyonu.
ID24173A (id) 1,2,3,4,5,6 heksahidro-2-6-metano-3-benzazosin-10-ol, proses pembuatan dan penggunannya untuk obat-obatan
HUP9800373A3 (en) Steroide compounds of anticeptive and antiosteoporosive activity, process for producing them and pharmaceutical compositions containing the same
AU4659199A (en) Process for the preparation of urea
ID26506A (id) Turunan-turunan n-fenilamida dan n-piridilamida, metode pembuatannya dan komposisi-komposisi farmasi yang mengandungnya
ID27539A (id) Proses pembuatan senyawa-senyawa pirazolo [4,3-d]pirimidin-7-ona-3-piridilsulfonil dan senyawa-senyawa antaranya
GB2344586B (en) Isoquinuclidine derivatives,method of manufacturing the same and therapeutic agents for hypercholesterolemia containing these compounds